The Dow® Target 10 Portfolio, March 2012
Series
The Strategy
The Dow® Target 10 Mar. '12 - Term 3/28/13 (The Dow®
Target 10 Portfolio) is a unit investment trust which invests in a fixed portfolio
of stocks for approximately 13 months. The portfolio adheres to a simple strategy
of investing in an equally-weighted portfolio of the ten highest dividend-yielding
stocks of the Dow Jones Industrial AverageSM (DJIASM).
The portfolio seeks above-average total return; however, there is no assurance
the objective will be met.
The strategy is based on three important elements:
- Higher Dividend Yields - Blue-chip stocks with higher dividend yields may
indicate that the stocks are out of favor or may be undervalued.
- Industry Leaders - The companies included in the DJIASM are some of the
most widely-held and well-capitalized companies in the world.
- Discipline - The strategy dictates what to buy, when to buy, and when to
sell. No emotional judgments are made and the strategy remains the same.
If this strategy had been applied since 1972, investors would have realized
higher total returns than by investing in the entire DJIASM. It is important
to note that the past performance of the strategy is hypothetical and it is
not indicative of the future performance of The Dow® Target 10 Portfolio. Although
this unit investment trust terminates in approximately 13 months, the strategy
is long-term. Investors should consider their ability to pursue investing in
successive portfolios, if available. There may be tax consequences unless units
are purchased in an IRA or other qualified plan.
| Not FDIC Insured • Not Bank Guaranteed • May Lose Value |
| Standard Deviations* |
Average Annual Total Returns* |
|
DJIASM |
Strategy |
DJIASM |
Strategy |
| Since 1972 |
15.57% |
16.54% |
10.55% |
11.07% |
| 25 years |
15.70% |
17.24% |
10.56% |
7.83% |
| 20 years |
14.78% |
17.28% |
9.51% |
6.52% |
| 15 years |
16.12% |
18.93% |
6.70% |
3.08% |
| 10 years |
15.06% |
19.29% |
4.56% |
2.00% |
| 5 years |
17.28% |
22.17% |
2.37% |
-1.85% |
| 3 years |
17.63% |
23.14% |
14.89% |
14.54% |
| *Through 12/30/11 |
| Annual Total Returns |
| Year |
DJIASM |
Strategy |
| 1972 |
18.48% |
19.86% |
| 1973 |
-13.28% |
1.76% |
| 1974 |
-23.57% |
-3.18% |
| 1975 |
44.75% |
53.94% |
| 1976 |
22.82% |
32.91% |
| 1977 |
-12.84% |
-4.23% |
| 1978 |
2.79% |
-2.48% |
| 1979 |
10.55% |
10.59% |
| 1980 |
22.16% |
25.32% |
| 1981 |
-3.57% |
5.03% |
| 1982 |
27.11% |
24.83% |
| 1983 |
25.96% |
36.52% |
| 1984 |
1.30% |
5.49% |
| 1985 |
33.55% |
27.38% |
| 1986 |
27.10% |
33.07% |
| 1987 |
5.48% |
3.31% |
| 1988 |
16.14% |
22.04% |
| 1989 |
32.19% |
23.95% |
| 1990 |
-0.56% |
-10.10% |
| 1991 |
24.19% |
32.70% |
| 1992 |
7.41% |
5.31% |
| 1993 |
16.93% |
24.38% |
| 1994 |
5.01% |
1.75% |
| 1995 |
36.87% |
34.07% |
| 1996 |
28.89% |
25.55% |
| 1997 |
24.94% |
18.97% |
| 1998 |
18.15% |
8.08% |
| 1999 |
27.21% |
2.59% |
| 2000 |
-4.71% |
3.32% |
| 2001 |
-5.43% |
-5.16% |
| 2002 |
-15.01% |
-11.04% |
| 2003 |
28.26% |
25.31% |
| 2004 |
5.30% |
1.89% |
| 2005 |
1.72% |
-7.39% |
| 2006 |
19.03% |
27.21% |
| 2007 |
8.87% |
-0.50% |
| 2008 |
-31.92% |
-39.10% |
| 2009 |
22.70% |
14.40% |
| 2010 |
14.10% |
16.48% |
| 2011 |
8.34% |
13.92% |
| 2/29/12 |
6.54% |
1.09% |
Past performance is no guarantee of future results and the actual current
performance of the portfolio may be lower or higher than the hypothetical performance
of the strategy. Hypothetical returns for the strategy in certain years were
significantly higher than the returns of the DJIASM. Hypothetical strategy returns
were the result of certain market factors and events which may not be replicated
in the future. You can obtain performance information which is current through
the most recent month-end by calling First Trust Portfolios L.P. at 1-800-621-1675
option 2. Investment return and principal value of the portfolio will fluctuate
causing units of the portfolio, when redeemed, to be worth more or less than
their original cost.
Simulated strategy returns are hypothetical, meaning that they do not represent actual trading, and, thus, may not reflect material economic and market factors, such as liquidity constraints, that may have had an impact on actual decision making. The hypothetical performance is the retroactive application of the strategy designed with the full benefit of hindsight. Strategy
returns reflect a sales charge of 2.95% in the first year, 1.95% in subsequent
years, estimated annual operating expenses of 0.184%, plus organization costs,
but not taxes or commissions paid by the portfolio to purchase securities. Returns
assume that all dividends received during a year are reinvested monthly.
Actual portfolio performance will vary from that of investing in the strategy
stocks because it may not be invested equally in these stocks and may not be
fully invested at all times. It is important to note that the strategy may underperform
the DJIASM in certain years and may produce negative results.
The DJIASM consists of 30 U.S. stocks chosen by the editors of The
Wall Street Journal as being representative of American industry. The index
cannot be purchased directly by investors.
Standard Deviation is a measure of price variability (risk). A higher degree of variability indicates more volatility and therefore greater risk.
You should consider the portfolio's investment objectives, risks, and
charges and expenses carefully before investing. Contact your financial advisor
or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus,
which contains this and other information about the portfolio. Read it carefully
before you invest.
Risk Considerations:
An investment in this unmanaged unit investment trust should be made with an
understanding of the risks involved with owning common stocks, such as an economic
recession and the possible deterioration of either the financial condition of
the issuers of the equity securities or the general condition of the stock market.
You should be aware that the portfolio is concentrated in stocks in the health care sector which involves additional risks, including limited diversification. The companies engaged in the health care sector are subject to fierce competition, high research and development costs, governmental regulations, loss of patent protection, and changing consumer spending trends. In addition, President Obama recently signed the Health Care and Education Affordability Reconciliation Act of 2010, which is expected to have significant implications for companies in the health care sector.
The value of the securities held by the trust may be subject to steep declines
or increased volatility due to changes in performance or perception of the issuers.
The Dow Jones Industrial AverageSM is a product of Dow Jones Indexes,
a licensed trademark of CME Group Index Services LLC ("CME"), and has been licensed
for use. "Dow Jones®", "The Dow®", "Dow
Jones Industrial AverageSM" and "Dow Jones Indexes" are service
marks of Dow Jones Trademark Holdings, LLC ("Dow Jones"), and have been licensed
to CME and have been sublicensed for use for certain purposes by First Trust.
The Dow® Target 10 Portfolio, based on the Dow Jones Industrial
AverageSM, is not sponsored, endorsed, sold or promoted by Dow Jones,
CME or their respective affiliates and none of them makes any representation
regarding the advisability of investing in such products.